Phase I/II trial of docetaxel and carboplatin as a first-line therapy in patients with stage IV non-small-cell lung cancer

A phase I/II study was conducted to determine the maximum-tolerated dose, the safety and tolerability, and the clinical efficacy of carboplatin and docetaxel in combination in patients with stage IV non-small-cell lung cancer. Patients with measurable, previously untreated, good performance status,...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Lung 2006-06, Vol.184 (3), p.133-139
Hauptverfasser:	Kataoka, Kensuke, Suzuki, Ryujiro, Taniguchi, Hiroyuki, Noda, Yasunobu, Shindoh, Joe, Matsumoto, Syuichi, Watanabe, Yoshiaki, Honda, Kousuke, Suzuki, Kiyoshi, Baba, Kenji, Imaizumi, Kazuyoshi, Kume, Hiroaki, Hasegawa, Yoshinori, Takagi, Kenzo
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Antineoplastic Agents - administration & dosage Antineoplastic Agents - adverse effects Antineoplastic Combined Chemotherapy Protocols Carboplatin - administration & dosage Carboplatin - adverse effects Carcinoma, Non-Small-Cell Lung - drug therapy Carcinoma, Non-Small-Cell Lung - mortality Carcinoma, Non-Small-Cell Lung - pathology Chemotherapy Clinical trials Drug dosages Female Humans Lung cancer Lung Neoplasms - drug therapy Lung Neoplasms - mortality Lung Neoplasms - pathology Male Middle Aged Neoplasm Staging Survival Rate Taxoids - administration & dosage Taxoids - adverse effects
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!